Shares of Kodiak Sciences Inc. (KOD) are soaring more than 5% in pre-market trading on Monday, driven by a significant target price increase from Wall Street analyst firm H.C. Wainwright. The biotechnology company's stock is reacting positively to this more optimistic outlook, despite the maintained neutral rating.

H.C. Wainwright raised its target price for Kodiak Sciences to $5 from $3, representing a substantial 67% increase. This adjustment reflects growing confidence in the company's prospects and has caught the attention of investors. The pre-market rally suggests that market participants are reevaluating the stock's potential in light of this new analyst perspective.

While the target price hike has injected optimism into the market, it's worth noting that H.C. Wainwright maintained its neutral rating on the stock. This implies a cautious approach, balancing the company's potential with possible risks. As the regular trading session begins, investors will be closely watching to see if the early momentum can be sustained throughout the day.